HR 1193 · 117th Congress · Health

Cardiovascular Advances in Research and Opportunities Legacy Act

Introduced 2021-02-22· Sponsored by Rep. Barr, Andy [R-KY-6]· House

Bill Progress

1
Introduced
Committee
House Vote
4
Senate
Enacted
Latest: Became Public Law No: 117-244.(2022-12-20)

Plain Language Summary

[AI summary unavailable — showing source text] Cardiovascular Advances in Research and Opportunities Legacy Act This bill expands research on valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart. The National Institutes of Health must consult with the National Heart, Lung, and Blood Institute to conduct or support research on the disease, including on mitral valve prolapse. This occurs when the valve between the chambers of the left side of the heart seals improperly. The Centers for Disease Control and Prevention (CDC) must develop best practices to treat valvular heart disease. The CDC may also carry out other projects to increase awareness of and reduce deaths from the disease.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (20)

3 Democrats17 Republicans